Details for Patent: 9,693,978

Which drugs does patent 9,693,978 protect, and when does it expire?

Patent 9,693,978 protects NAPROXEN SODIUM and is included in one NDA.

This patent has fifteen patent family members in thirteen countries.

Summary for Patent: 9,693,978

Title:	Solvent system for enhancing the solubility of pharmaceutical agents
Abstract:	Liquid and semi-solid pharmaceutical compositions, which can be administered in liquid form or can be used for preparing capsules, are described herein. The composition comprises the salt of one ore more active agents, polyethylene glycol, 0.2-1.0 mole equivalents of a de-ionizing agent per mole of active agent, and water. The pH of the composition is adjusted within the range of 2.5-7.5. The de-ionizing agent causes partial de-ionization (neutralization) of the salt of the active agent resulting in enhanced bioavailability of salts of weakly acidic, basic or amphoteric active agents as well as lesser amounts of polyethylene glycol (PEG) esters.
Inventor(s):	Chidambaram; Nachiappan (Salt Lake City, UT), Fatmi; Aqeel (Greensboro, NC)
Assignee:	Banner Life Sciences LLC (High Point, NC)
Application Number:	14/977,808
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 9,693,978
Patent Claim Types: see list of patent claims	Use; Composition; Dosage form;

Drugs Protected by US Patent 9,693,978

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Bionpharma	NAPROXEN SODIUM	naproxen sodium	CAPSULE;ORAL	021920-001	Feb 17, 2006		OTC	Yes	Yes			Y

International Family Members for US Patent 9,693,978

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Canada	2600023
China	101166520
China	102940887
Cyprus	1118321